XLRN
Acceleron Pharma Inc.
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
136 hedge funds and large institutions have $863M invested in Acceleron Pharma Inc. in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-10
Holders Change %
-6.85%
% of All Funds
3.39%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
21
Increased
45
Reduced
46
Closed
25
Calls
$1.14M
Puts
$2.3M
Net Calls
-$1.16M
Net Calls Change
+$192K
Top Buyers
| 1 |
BlackRock
New York
|
$97.3M |
| 2 |
AG
Artal Group
Luxembourg
|
$19.9M |
| 3 |
Millennium Management
New York
|
$14.4M |
| 4 |
GTC
Ghost Tree Capital
New York
|
$10.6M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$41.1M |
